Silent hypoxemia in a patient with severe SARS-CoV-2 pneumonia
Patients with COVID-19 are typically characterized by severe lung injury with the development of acute respiratory failure. However, in some patients, subjective well-being may remain relatively satisfactory for a long time and, despite severe hypoxemia, they do not complain of shortness of breath. Case report. We observed a 65-year-old man hospitalized with severe SARS-CoV-2 pneumonia, low level of blood oxygen saturation, but at the same time without complaints of shortness of breath. Only as the disease progressed with a decrease in oxygen saturation when breathing atmospheric air (SpO2 ) lower than 85% he began to notice a feeling of lack of air. The patient’s condition worsened and as a result, he died in the intensive care unit from multiple organ failure. Discussion. This case clearly illustrates one more feature of the course of pneumonia associated with the novel SARSCoV-2 coronavirus and shows that SpO2 measurement is one of the leading objective criterion that allows a doctor to assess the real severity of a patient’s condition with COVID-19..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Сеченовский вестник - 11(2020), 2, Seite 87-91 |
| Sprache: |
Russisch |
|---|
| Beteiligte Personen: |
A. D. Palman [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Acute respiratory failure |
|---|
| doi: |
10.47093/2218-7332.2020.11.2.87-91 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ078841844 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ078841844 | ||
| 003 | DE-627 | ||
| 005 | 20230503012439.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230307s2020 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.47093/2218-7332.2020.11.2.87-91 |2 doi | |
| 035 | |a (DE-627)DOAJ078841844 | ||
| 035 | |a (DE-599)DOAJ460a7258bd7749d9ad8397f1b8c73a07 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 050 | 0 | |a R5-920 | |
| 100 | 0 | |a A. D. Palman |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Silent hypoxemia in a patient with severe SARS-CoV-2 pneumonia |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Patients with COVID-19 are typically characterized by severe lung injury with the development of acute respiratory failure. However, in some patients, subjective well-being may remain relatively satisfactory for a long time and, despite severe hypoxemia, they do not complain of shortness of breath. Case report. We observed a 65-year-old man hospitalized with severe SARS-CoV-2 pneumonia, low level of blood oxygen saturation, but at the same time without complaints of shortness of breath. Only as the disease progressed with a decrease in oxygen saturation when breathing atmospheric air (SpO2 ) lower than 85% he began to notice a feeling of lack of air. The patient’s condition worsened and as a result, he died in the intensive care unit from multiple organ failure. Discussion. This case clearly illustrates one more feature of the course of pneumonia associated with the novel SARSCoV-2 coronavirus and shows that SpO2 measurement is one of the leading objective criterion that allows a doctor to assess the real severity of a patient’s condition with COVID-19. | ||
| 650 | 4 | |a covid-19 | |
| 650 | 4 | |a sars-cov-2 | |
| 650 | 4 | |a acute respiratory failure | |
| 650 | 4 | |a silent hypoxemia | |
| 653 | 0 | |a Medicine (General) | |
| 700 | 0 | |a D. A. Andreev |e verfasserin |4 aut | |
| 700 | 0 | |a S. A. Suchkova |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Сеченовский вестник |d Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 2021 |g 11(2020), 2, Seite 87-91 |w (DE-627)DOAJ078607779 |x 26583348 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2020 |g number:2 |g pages:87-91 |
| 856 | 4 | 0 | |u https://doi.org/10.47093/2218-7332.2020.11.2.87-91 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/460a7258bd7749d9ad8397f1b8c73a07 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.sechenovmedj.com/jour/article/view/244 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2218-7332 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2658-3348 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2020 |e 2 |h 87-91 | ||